Form 4: Varex Director Chertoff Acquires 12,331 Stock Units
Insider Transaction Disclosure
Varex Imaging Corp. Director Jocelyn D. Chertoff was granted 12,331 Deferred Stock Units, aligning interests with shareholders.
Summary
- Jocelyn D. Chertoff, a Director of Varex Imaging Corp. (VREX), acquired 12,331 Deferred Stock Units (DSUs).
- The transaction date for this acquisition was February 12, 2026.
- Each DSU converts into one share of Varex Imaging Corp. common stock.
- The DSUs vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders following the grant date.
- Vested shares will be delivered to Ms. Chertoff upon the earliest of the third anniversary of the grant date, a change in control, or her termination of service for any reason.
- Following this transaction, Ms. Chertoff beneficially owns 12,331 Deferred Stock Units directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard corporate governance practices for director compensation and aligning insider interests with shareholder value, without indicating any material operational changes.
Positives
- The grant of Deferred Stock Units to a director aligns management's interests with those of shareholders, encouraging long-term value creation.
- The vesting schedule promotes retention and continued engagement of the director with the company's performance.
Future Outlook
The Deferred Stock Units are subject to a vesting schedule, with full vesting occurring on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders. Delivery of the vested shares is deferred until the earlier of the third anniversary of the grant date, a change in control, or the director's termination of service.
Industry Context
StockSavvy.ai notes that the grant of equity-based compensation, such as Deferred Stock Units, to non-employee directors is a common practice across various industries. This method is widely adopted to attract and retain qualified board members while aligning their financial interests with the long-term performance of the company and its shareholders.
Comparison to Industry Standards
- Equity compensation for directors, including DSUs, is a standard practice in publicly traded companies across sectors like healthcare technology, which Varex Imaging operates in. Companies such as Hologic, Inc. (HOLX) and Agfa-Gevaert (AGFB.BR) also utilize similar equity-based incentives for their non-executive directors to foster long-term commitment and performance alignment.
- The vesting period of approximately one year is typical for director equity grants, ensuring continued service and oversight.
- The deferral of share delivery until a later date or specific events (like termination or change in control) is also a common feature, often used for tax planning purposes for the recipient and to further align long-term interests.
Related Party Transactions
- The grant of 12,331 Deferred Stock Units to Jocelyn D. Chertoff, a Director of Varex Imaging Corp., represents a standard compensation transaction with a related party.
Stakeholder Impact
- Shareholders: The grant of equity to a director generally aligns the director's financial interests with those of the shareholders, potentially leading to more shareholder-centric decision-making.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- The Deferred Stock Units will vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders that occurs after the grant date.
- Vested shares will be delivered to the reporting person upon the earlier of the third anniversary of the grant date, a change in control, or the reporting person's termination of service for any reason.
Key Dates
| Date | Description |
|---|---|
| 02/12/2026 | Date of grant for 12,331 Deferred Stock Units to Director Jocelyn D. Chertoff. |
| 02/12/2027 | One-year anniversary of the grant date, a potential vesting date for the Deferred Stock Units. |
Recommendation
holdThis Form 4 filing details a routine equity grant to a director, which is a standard compensation practice. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction primarily serves to align the director's interests with shareholders, which is generally a positive but not a catalyst for significant price movement.
Keywords
Varex Imaging, VREX, Form 4, Deferred Stock Units, DSU, Insider Transaction, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.